The nonapeptide hormone oxytocin exerts many important biological functions, including uterine contractions during parturition and milk ejection during lactation. The manifold effects of oxytocin are mediated by a single oxytocin receptor (OTR) type, a member of the super-family of G-protein-coupled receptors. There is accumulating recent evidence that certain G-protein-coupled receptors exist in the form of oligomeric complexes. Here we demonstrate, using two different co-immunoprecipitation strategies as well as bioluminescence resonance energy transfer techniques, that the OTR is capable of forming oligomeric complexes in vivo and that these complexes exist at the cell surface membrane. The human OTR was N-terminally tagged with either a Myc or Flag epitope and transiently expressed in COS-7 cells. Cell lysates were immunoprecipitated using an anti-Flag antibody and analyzed by SDS-PAGE and Western blotting using an anti-Myc antibody, or vice versa. Either strategy provided evidence for the co-precipitation of Myc-or Flag-tagged OTR respectively.
Introduction
The receptor for the multifunctional cyclic nonapeptide oxytocin (OT) is a G-protein-coupled receptor (GPCR) that forms part of the OT/ vasopressin receptor family. The OT receptor (OTR) is able to couple functionally to both Gq/11 and Gi proteins (Ku et al. 1995 , Strakova & Soloff 1997 . OTR activation triggers multiple molecular events, including an increase in intracellular free calcium concentration, activation of mitogenactivated protein kinase, protein kinase-C and myosin light-chain kinase and synthesis of prostaglandin E2 (Zingg & Laporte 2003) . The mechanisms by which the multiple OTR signaling cascades are specifically activated and modulated are still incompletely understood. Several studies have assessed the ligand/receptor interactions between the OTR and OT by photoaffinity labeling (Breton et al. 2001) , site-directed mutagenesis (Fanelli et al. 1999 , Hawtin et al. 2001 or the construction of receptor chimeras (Postina et al. 1996) .
All these studies refer to the OTR in its monomeric form. However, a growing body of evidence now indicates that certain GPCRs function as oligomeric complexes , Eidne 2002 . Complexes can form between the same or different classes of receptors and the oligomerization process can be either dependent on (Patel et al. 2002) or independent of ligand binding (Issafras et al. 2002) . Furthermore, many reports show the importance of GPCR oligomerization for multiple aspects of receptor biology such as intracellular signaling, trafficking, pharmacology and sequestration .
A complete understanding of OTR structure/ function relationships requires a definition of the oligomeric state of the OTR in vivo. As a first step towards resolving this problem, we have applied different co-immunoprecipitation strategies as well as an in vivo approach. We now report that the human OTR can form dimers and oligomers as demonstrated in vitro by co-immunoprecipitation and in vivo by bioluminescence resonance energy transfer (BRET) in transiently transfected COS-7 cells. The characterization of such complexes will be a prerequisite for a full understanding of the mechanism of OTR action.
While the present paper was under review, the formation of OTR dimers during biosynthesis was described by S. Terrillon et al. (2003) .
Materials and methods

DNA plasmids
Plasmids encoding the wild-type human OTR or recombinant OTRs tagged at the N-terminus with either a Myc or a Flag epitope were a generous gift of Dr Bice Chini, Milan, Italy (Flag-OTR and Myc-OTR respectively). The plasmid B2R-YFP, encoding the human bradykinin B2 receptor with the coding region for the yellow fluorescent protein (YFP) added in frame at its C-terminus, was a gift from Dr S A Laporte, Montreal, Canada. The following additional constructs were derived: 3 Flag-OTR, an OTR construct with a triple Flag epitope added to the N-terminus by inserting the OTR coding sequence in frame into the expression vector p3 Flag-CMV-7·1 (Sigma); OTR-luc, an OTR construct with the coding sequence for Renilla luciferase added in frame to the OTR C-terminus by inserting the OTR coding region into the vector pRL-CMV (Promega); OTR-YFP, an OTR construct with the coding sequence for YFP added in frame to the OTR C-terminus, obtained by inserting the OTR coding region in frame into the vector pEYFP (Clontech, Palo Alto, CA, USA). The sequence integrity of all constructs was verified by dideoxy sequencing.
Tissue culture, transfections and co-immunoprecipitations COS-7 cells were cultured in DMEM 'high glucose' media (Gibco) supplemented with 10% fetal bovine serum. The cells were cultured in the absence of antibiotics to ensure contamination-free conditions. The day before transfection, COS-7 cells were plated at a density of 2 10 6 cells per 10 cm dish. Cells were transiently transfected with a total of 5 µg DNA using Effectene (Qiagen) according to the manufacturer's recommendations. Cell medium was changed the following day. Forty-eight hours post-transfection, cells were lysed at room temperature for 30 min in 1 ml lysate buffer (25 mM Hepes (pH 7·4), 5 mM EDTA, 50 mM NaCl, 10% glycerol, 1% Triton X-100, 50 mM NaF, 30 mM sodium pyrophosphate and protease inhibitors (1 µg/ml each of aprotinin, leupeptin and pepstatin A, and 1 mM phenylmethylsulfonyl fluoride)). To avoid any non-specific OTR aggregation caused by disulfide bond formation, the sulfhydryl alkylating reagent iodoacetamide (IOA) was present at a concentration of 10 mM during the solubilization and immunoprecipitation steps. The following steps were done at 4 C, except where stated otherwise. The lysates were cleared by centrifugation at 13 400 g for 10 min and protein content of the supernatant was evaluated using a BCA Protein Assay Reagent Kit (Pierce, Brockville, Ontario, Canada). For coimmunoprecipitation, 500-1000 µg protein/ml were mixed with either 10 µg anti-Myc antibody (clone 9E10; Upstate Biotechnology, Lake Placid, NY, USA) or 4 µg anti-Flag antibody (Sigma) for 3 h. The antibody-antigen complexes were precipitated by protein G-linked Sepharose (Pharmacia) for 30 min and the beads were washed twice with lysate buffer (without IOA). The beads were resuspended for 15 min at room temperature in 20 µl urea buffer (9·6 M urea, 4% SDS, 250 mM Tris (pH 6·8), 10% glycerol, 130 mM dithiothreitol (DTT) and bromophenol blue). In some experiments, to avoid non-reduced immunoglobulins masking high molecular complexes, the coimmunoprecipitation was performed using the anti-Flag antibody covalently linked to protein G Sepharose according to the protocol of Schneider et al. (1982) . The denatured coimmunoprecipitation products were subjected to SDS-PAGE analysis and then electro-blotted onto PVDF membranes (Immobilon-P; Millipore, Bedford, MA, USA) overnight at 45 V in 10 mM 3-(cyclohexylamino)-1-propane-sulfonic acid buffer (pH 11·0) containing 10% methanol. The tagged receptors were immunodetected using the same antibodies used previously for coimmunoprecipitation in conjunction with a secondary anti-mouse antibody conjugated to horseradish peroxidase C. Bands were visualized using a chemiluminescent detection system (SuperSignal; Pierce).
Cell surface co-immunoprecipitation
Forty-eight hours post-transfection, COS-7 cells were stimulated or not by 100 nM OT for different times at 37 C. At the end of the incubation period, the cells were washed twice with ice-cold PBS, followed by one wash in Krebs/Hepes buffer (146 mM NaCl, 4·2 mM KCl, 0·5 mM MgCl 2 , 10 mM Hepes (pH 7·4) and 5·9 mM glucose). Five milliliters of Krebs/Hepes containing 0·5% BSA and 10 µg/ml anti-Flag antibody were added to each dish and left overnight at 4 C. The plates were extensively washed with PBS and cells were lysed as before except that no IOA was added to the lysate buffer. Whole-cell lysates were then incubated with the protein G Sepharose and co-immunoprecipitation complexes were treated and analyzed as mentioned earlier.
BRET
The oligomerization of OTR in vivo was assessed by BRET in transiently transfected COS-7 cells. Twenty-four hours after transfection, cells were replated onto a 96-well plate at 10 5 cells/well. The following day, medium was replaced with 100 µl Krebs/Hepes buffer following three washes with the same buffer. Coelenterazine h (Molecular Probes, Eugene, OR, USA) was added at a final concentration of 10 µM, and luminescence emission was measured immediately thereafter at both 460 nm and 530 nm using an FL 600 spectrofluorometer (Bio-Tek Instruments Inc., Winooski, VT, USA). The BRET ratio was calculated using the formula: (luminescence 530 nm Bg 530 nm )/(luminescence 460 nm Bg 460 nm ) where Bg x is the background at wavelength x nm, obtained by taking a luminescence measurement in the absence of substrate.
Results
Evidence for OTR oligomerization by co-immunoprecipitation
To investigate whether OTR can form dimers and oligomers, we first developed a coimmunoprecipitation strategy using two different OTR constructs that carried at their N-terminus either the Flag (Flag-OTR) or the Myc epitope (Myc-OTR). Co-immunoprecipitation of Flag immunoreactivity with the anti-Myc antibody or co-immunoprecipitation of Myc immunoreactivity with the anti-Flag antibody was taken as evidence for the existence of a physical association between Flag-OTR and Myc-OTR. The results of coimmunoprecipitation experiments using either of these approaches are shown in Fig. 1 . Mycimmunoreactive bands were detected by Western blotting of Flag immunoprecipitates from cells transfected with both Flag-OTR and Myc-OTR plasmids (Fig. 1A, lane 1) , but not from cells transfected with Myc-OTR alone (lane 2). Conversely, Flag-immunoreactive bands were detected by Western blotting of Myc immunoprecipitates from cells transfected with both Flag-OTR and Myc-OTR plasmids (Fig. 1B, lane  4) , but not from cells transfected with Flag-OTR alone (lane 5). The bands detected corresponded to the molecular mass of the glycosylated form of the OTR at 70-80 kDa (Breton et al. 2001) , the non-glycosylated form of the OTR at 38 kDa (Breton et al. 2001 ) and higher molecular mass complexes that correspond most likely to SDSresistant dimers and oligomers.
Receptor density in this in vitro system was 635 47 fmol/mg protein (n=3), as determined by Scatchard analysis. Because, in vivo, OTR densities can reach up to 1850 and 7300 fmol/mg protein in myometrium and endometrium respectively (Fuchs et al. 1992) , these levels were well within the physiological range. In addition, when OTR expression levels were lowered by lowering the amount of expression plasmid used for transfection, OTR oligomers remained detectable by the co-immunoprecipitation approach at receptor densities as low as 50 fmol/mg protein.
Additional experiments were undertaken to assess the specificity of these observations. To exclude the possibility that the observed oligomerization of OTR could be due to artifactual oligomerization occurring after solubilization, we mixed, prior to immunoprecipitation, lysates from two cell populations, each expressing one of the two tagged receptor types. No specific bands were detected in this case (Fig. 1A, lane 3) . To test whether the observed co-immunoprecipitation could be due to incomplete membrane solubilization or non-specific protein aggregation, we assessed whether abundant and ubiquitous proteins were co-immunoprecipitated. To this end, we determined whether Na/K-ATPase (a marker of the plasma membrane) or the chaperone protein BiP/GRP74 (a marker of the endoplasmic reticulum) was present in immunoprecipitates. Neither of these proteins was detected in immunoprecipitates ( Fig. 2A and B) , whereas OTR coimmunoprecipitation remained readily detectable (Fig. 2C) .
OTR oligomers are insensitive to reducing conditions
There is no consensus in the literature whether GPCR oligomerization involves the formation of disulfide bonds. Whereas some GPCR oligomers have been reported to be sensitive to reducing conditions, others have been shown to be insensitive. To test the involvement of disulfide bonds in the formation of OTR oligomers, we compared the band pattern obtained by Western blotting of co-immunoprecipitation samples treated or not with the reducing agent DTT. In the absence of DTT treatment, a high molecular mass aggregate was seen (Fig. 3, lane 3) . If de novo formation of disulfide bonds in vitro during the extraction and precipitation steps was prevented by addition of IOA, only bands responding to receptor monomers, SDS-resistant dimers and some higherorder oligomers were detected (Fig. 3, lane 2) . This indicated that the high molecular mass aggregates seen in lane 3 were due to disulfide bond formation that had occurred during the solubilization and precipitation steps in the non-reducing in vitro environment. As shown in lane 1, addition of the reducing agent DTT after co-immunoprecipitation resulted in the same band pattern as the one observed in lane 2, indicating that receptor dimerization and oligomerization that occurs in vivo is not sensitive to reducing agents and thus is not dependent on the formation of disulfide bonds.
OTR oligomers are present at the cell surface and are modulated by ligand addition The experiments described above provided evidence for the existence of OTR oligomers; however, they did not provide any information with respect to the subcellular distribution of these oligomers. To answer specifically the question whether OTR oligomers were present at the cell surface, the antibody used for coimmunoprecipitation was added directly to intact living cells, thus limiting antibody access to cell surface molecules, as described (Zeng & Wess 1999) . To this end, cells expressing Myc-OTR as well as an OTR endowed with a triple N-terminal Flag tag (3 Flag-OTR) were exposed overnight to an anti-Flag antibody and, following extensive washing, antibody-tagged complexes were immunoprecipitated using protein G Sepharose beads and analyzed by immunoblotting using an anti-Myc antibody. As shown in Fig. 4 , immune complexes containing Myc immunoreactivity could be efficiently precipitated by this strategy, indicating the presence of 3 Flag-OTR/Myc-OTR dimers or oligomers at the cell surface.
The role of receptor ligands in the formation of receptor oligomers is controversial. For some receptor systems, oligomerization is reported to be induced by agonists (Patel et al. 2002) , suppressed by agonists (Cvejic & Devi 1997) or independent of ligand addition (Ayoub et al. 2002) . Therefore we investigated the role of OT addition on the amount of cell surface oligomers detectable with the present approach. The fact that, as described in the previous experiments, OTR oligomers were detected independently of ligand addition indicates that OTR oligomerization can occur in the absence of agonist. However, as shown in Fig. 4C , addition of agonist led to a rapid and significant decrease in the amount of detectable surface oligomer complexes recovered by co-immunoprecipitation.
Evidence for OTR oligomerization in vivo using BRET
The co-immunoprecipitation experiments described so far were based on the detection of receptor oligomers in cell extracts. Thus they provided strong evidence for, but no direct proof of, receptor oligomerization occurring in vivo. Therefore, we next investigated the existence of receptor oligomers in real time within living cells using BRET. Briefly, BRET is a technique used to detect protein/protein interaction in intact cells and is based on a non-radiative transfer of energy between the luminescent donor Renilla luciferase and the fluorescent acceptor YFP (Xu et al. 1999) . Whereas light emission by luciferase is induced by substrate addition, the characteristic fluorescence emission of YFP is strictly dependent on its close proximity to luciferase upon luminescence emission. This technique has recently been used to assess oligomerization of GPCRs in intact cells , Eidne 2002 ). We assessed OTR oligomerization by BRET by transiently expressing in COS-7 cells two versions of the OTR carrying at their C-terminus either the Renilla luciferase protein (OTR-luc) or the YFP (OTR-YFP). Cells were exposed to the membrane-permeable Renilla luciferase substrate coelenterazine h, and bioluminescence was measured using a spectrofluorometer. As shown in Fig. 5 , co-transfection of cells with a luciferase-containing OTR-luc and OTR-YFP led to a marked and reproducible increase in the BRET ratio compared with OTR-luc-only expressing cells (bar 3 vs 1). Furthermore, no signal was detected when OTR-YFP was expressed alone, excluding any luciferase-independent fluorescence emission by YFP (bar 2). Three additional control experiments further validated these observations. First, no significant increase in the BRET ratio was observed when OTR-luc was co-expressed with free YFP, not attached to the OTR (bar 4). Secondly, no change in the BRET ratio relative to control was observed when a mix of two cell populations was used, each expressing separately OTR-luc and OTR-YFP (bar 5), demonstrating that both tagged receptors have to be co-expressed in the same cell in order to induce a change in the BRET ratio. Thirdly, no significant change in the BRET ratio was observed when the OTR-YFP plasmid was replaced by B2R-YFP, a plasmid encoding the human bradykinin B2 receptor fused to YFP (bar 6).
Finally we assessed the effect of agonist addition on the observed BRET ratio. In contrast to our findings using the co-immunoprecipitation approach, no significant change in the BRET ratio was observed upon the addition of agonist (bars 7 vs 8). However, the fact that a significant effect on the BRET ratio was observed in the absence of agonist is consistent with the previous observation that OTR oligomers were found in the absence of ligand.
Discussion
The present report provides evidence using two independent approaches that the OTR exists in dimeric and oligomeric forms at the cell surface in vivo. First, using a co-immunoprecipitation approach, we demonstrated the presence of SDS-sensitive and -resistant dimers and oligomers. By the use of sulfhydryl alkylating agents, we excluded the possibility that the observed co-immunoprecipitation was due to artefactual aggregation during receptor solubilization or immunoprecipitation. Moreover, OTR oligomerization does not involve the formation of disulfide bonds. Secondly, the concept of OTR oligomerization is further supported by the detection of BRET in intact living cells. Oligomerization was observed at receptor densities that were well within the physiological range.
The constitutive nature of OTR oligomers suggests that oligomerization may be involved in receptor folding and trafficking . Using a cell surface co-immunoprecipitation strategy, we determined that OTR oligomers are indeed present at the cell surface. Treatment of cells with OT led to a decrease of surface OTR recovered by co-immunoprecipitation, implying a change in receptor/receptor interactions. Because this phenomenon correlates, in time, with receptor activation, it is possible that it may be part of the receptor activation process. A transition of the receptor from an oligomeric to a monomeric state was recently proposed to be involved in the activation of the thyrotropin receptor (Latif et al. 2002) .
However, the possibility cannot be ruled out that agonist binding does not induce monomerization per se but induces a conformational change in the receptor structure that leads to a decrease in the stability of receptor oligomers and, consequently, to receptor monomerization during the immunoprecipitation step. This hypothesis could explain why, after agonist addition, we observed an apparent decrease in OTR cell surface oligomers with the co-immunoprecipitation approach but were unable to find any significant changes in the BRET ratio. 2) or with both vectors in combination (lanes 3, 7 and 8). As a control, BRET was also assessed in cells co-transfected with OTR-luc and an expression vector for the YFP protein alone (lane 4) or in a mixture of two cell populations transfected separately with either OTR-luc or OTR-YFP (lane 5) and in cells co-transfected with OTR-luc and B2R-YFP, an expression vector encoding the human bradykinin B2 receptor fused to YFP (lane 6). To test the possible influence of agonist on the BRET ratio, cells were pretreated with 100 nM OT or vehicle for 5 min at 37°C prior to BRET analysis (lanes 7 and 8). Each bar represents the mean±S.E.M. of BRET ratios determined in four independent experiments. Receptor densities were 425 and 310 fmol/mg protein for the OTR-YFP and B2R-YFP respectively.
